Skeletal recovery from hepatitis C-associated osteosclerosis (HCAO) following antiviral treatment
Related Experiment Video
Updated: Jun 2, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Rose-Marie Javier1, Marie-Christine de Vernejoul, Naji Afif
1Rheumatology Unit, Department of Rheumatology, hôpital de Hautepierre, University Hospital, 67000 Strasbourg, France. Rose-marie.Javier@chru-strasbourg.fr
Abstract:
Hepatitis C-associated osteosclerosis (HCAO) is characterized by increased bone mass following hepatitis C infection. We report here a case of HCAO that lasted 8 years before the patient received antiviral hepatitis treatment. Seven years after the antiviral treatment, the evolution of radiographs and densitometry showed skeletal recovery of osteosclerosis. This case strengthens the relationship between viral infection and osteosclerosis.
Related Concept Videos
Cirrhosis II: Pathophysiology
Osteoclasts in Bone Remodeling
Hepatitis
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Viral Hepatitis I: Introduction
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...